Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y capsular polysaccharide conjugated antigens (medicinal product) |
Count of active ingredient |
quatre |
false |
Inferred relationship |
Some |
|
|
Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y capsular polysaccharide conjugated antigens (medicinal product) |
Is a |
Vaccine product containing only Neisseria meningitidis serogroup C capsular polysaccharide conjugated antigen (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y capsular polysaccharide conjugated antigens (medicinal product) |
Plays role |
Active immunity stimulant role (role) |
true |
Inferred relationship |
Some |
|
|
Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y capsular polysaccharide conjugated antigens (medicinal product) |
Count of base of active ingredient |
un |
false |
Inferred relationship |
Some |
|
|
Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y capsular polysaccharide conjugated antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Neisseria meningitidis serogroup C capsular polysaccharide antigen conjugated |
true |
Inferred relationship |
Some |
1 |
|
Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y capsular polysaccharide conjugated antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Neisseria meningitidis serogroup A capsular polysaccharide antigen conjugated |
true |
Inferred relationship |
Some |
2 |
|
Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y capsular polysaccharide conjugated antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Neisseria meningitidis serogroup W135 capsular polysaccharide antigen conjugated |
true |
Inferred relationship |
Some |
3 |
|
Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y capsular polysaccharide conjugated antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antigen of Neisseria meningitidis serogroup Y capsular polysaccharide conjugated (substance) |
true |
Inferred relationship |
Some |
4 |
|
Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y capsular polysaccharide conjugated antigens (medicinal product) |
Is a |
Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y antigens (medicinal product) |
true |
Inferred relationship |
Some |
|
|
Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y capsular polysaccharide conjugated antigens (medicinal product) |
Is a |
Vaccine product containing only Neisseria meningitidis capsular polysaccharide antigen (medicinal product) |
true |
Inferred relationship |
Some |
|
|